Answers are grounded in this paper and cite their sources.
These findings identify a novel function of IL-17 in driving salivary dysfunction during pSS development and may provide a new therapeutic strategy for targeting SG dysfunction in pSS patients.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: